Fundraising Fox

Nuvig

22 employees on LinkedIn · 7 known investors

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.

BiotechHealthtechMedical Devices

Founders & leadership

PC
Pamela ConleyinChief Scientific Officer and Co-founder

Investors · 7

B Capital GroupManhattan Beach · $10M – $50M
B4 Capital$10M – $50M
Global BioAccess FundNew York · $10M
Mission BiocapitalSan Francisco · $500K
Sanofi VenturesCambridge · $5M
Digitalis VenturesreportedNew York · $100K – $10M
Norwest Venture PartnersreportedMenlo Park · $10M – $30M

Funding

SEC filings, press & company announcements

$161M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

The Week’s Biggest Funding Rounds: Tenstorrent And Nuvig Top Listnews.crunchbase.com · Dec 2024Nuvig pulls in $161M to make better immune drugs | BioPharma Divebiopharmadive.com · Dec 2024Nuvig raises $161M with 4 Big Pharmas in towfiercebiotech.com · Dec 2024Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune fieldendpoints.news · Dec 2024Nuvig Therapeutics Raises $161M in Series B Fundingfinsmes.com · Dec 2024Team | Nuvig Therapeuticsnuvigtx.com · Apr 2022

Frequently asked questions

What does Nuvig do?
Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.
Who founded Nuvig?
Nuvig was founded by Pamela Conley.
Who are Nuvig's investors?
Nuvig's investors include B Capital Group, B4 Capital, Global BioAccess Fund, Mission Biocapital, Sanofi Ventures, Digitalis Ventures, Norwest Venture Partners.
How much funding has Nuvig raised?
Nuvig has disclosed $161M raised across 1 round.